GNH USA

Europe — EMA

Meriofert Kit

GNH USA supplies Meriofert Kit (Follicle-Stimulating Hormone and Luteinising Hormone), a gonadotropin for infertility due to anovulation, ART

Follicle-Stimulating Hormone, Luteinising Hormone

Request sourcing

1
Pack/s

What is Follicle-Stimulating Hormone, Luteinising Hormone?

Follicle-Stimulating Hormone and Luteinising Hormone, the active ingredient in Meriofert Kit, is a gonadotropin presented as a sterile injectable solution for intramuscular or subcutaneous use. It is used to stimulate follicular development and ovulation in women with infertility related to anovulation, assisted reproductive technology cycles, or hypogonadotropic hypogonadism. GNH USA supplies Meriofert Kit as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Follicle-Stimulating Hormone, Luteinising Hormone used for?

Meriofert Kit, a gonadotropin used in reproductive endocrinology, is indicated for: - Infertility due to anovulation: stimulates follicular growth to induce ovulation. - Assisted reproductive technology (ART): supports controlled ovarian stimulation in IVF and related procedures. - Hypogonadotropic hypogonadism: replaces deficient gonadotropins to restore normal ovarian function.

What are the side effects of Follicle-Stimulating Hormone, Luteinising Hormone?

Common Side Effects: - Injection site pain or erythema. - Mild abdominal discomfort. - Nausea or mild gastrointestinal upset. - Headache.

Serious or Rare Side Effects: - Ovarian hyperstimulation syndrome (OHSS). - Multiple pregnancy (twins or higher order). - Severe allergic reaction (anaphylaxis). - Thromboembolic events (rare).

What precautions apply to Follicle-Stimulating Hormone, Luteinising Hormone?

When using Meriofert Kit, clinicians should consider the following precautions: - Monitor ovarian response: use ultrasound and estradiol levels to adjust dosing. - Avoid in active ovarian cysts: risk of rupture or exacerbation. - Screen for hypersensitivity: discontinue if allergic signs appear. - Use caution in patients with thyroid disease: hormone interactions may require adjustment. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Follicle-Stimulating Hormone, Luteinising Hormone interact with?

Meriofert Kit may interact with other medications as follows:

Major Interactions (Avoid): - GnRH agonists: can potentiate response and increase risk of OHSS. - High‑dose estrogen preparations: may interfere with monitoring and efficacy. - Thyroid hormone therapy: may alter gonadotropin metabolism.

Moderate Interactions (Monitor Closely): - Anticoagulants: monitor for bleeding at injection sites. - Corticosteroids: may affect ovarian response and hormone levels.

Frequently asked questions

What is Meriofert Kit used for?+
Meriofert Kit is prescribed to treat infertility caused by anovulation, to support ovarian stimulation in assisted reproductive technology procedures such as in‑vitro fertilisation, and to replace deficient gonadotropins in women with hypogonadotropic hypogonadism.
How does Follicle‑Stimulating Hormone and Luteinising Hormone work?+
The two hormones bind to specific FSH and LH receptors on ovarian cells. Activation of these receptors promotes follicle growth, estrogen production, and the LH surge that triggers ovulation, thereby facilitating the development of a mature oocyte for fertilisation.
What is the usual dose of Meriofert Kit?+
The dose of Meriofert Kit is individualised by the prescribing clinician based on the patient’s ovarian response, treatment protocol and underlying condition. Dosage regimens are not standardised and should follow the prescriber’s instructions.
Is Meriofert Kit safe during pregnancy or breastfeeding?+
Meriofert Kit is intended for use before conception to induce ovulation. Its safety in established pregnancy or while breastfeeding has not been established, and it should not be used during those periods unless specifically advised by a qualified healthcare professional.
How do I order Meriofert Kit from GNH USA?+
To order, submit an enquiry on the Meriofert Kit product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.
How does Meriofert Kit compare with other gonadotropin products?+
Meriofert Kit combines both FSH and LH activities in a single injectable formulation, which can simplify dosing compared with separate FSH‑only preparations. Clinical efficacy is comparable to other recombinant gonadotropins, while the safety profile reflects the class‑wide risks of ovarian stimulation.
How should Meriofert Kit be stored and handled?+
Store Meriofert Kit at 2‑8 °C in a refrigerator. Keep the product in its original packaging, protect it from light, and avoid freezing or shaking the vial. Do not use if the solution appears discoloured or contains particles.
How is Meriofert Kit administered?+
Meriofert Kit is administered by a healthcare professional via intramuscular or subcutaneous injection, typically into the thigh or abdomen. The exact injection technique and site should follow the prescriber’s guidance and standard aseptic procedures.
What are the most serious risks associated with Meriofert Kit?+
Serious risks include ovarian hyperstimulation syndrome, which can cause abdominal pain, rapid weight gain and, in severe cases, fluid accumulation; multiple pregnancy; severe allergic reactions; and rare thromboembolic events. Patients should be monitored closely for these complications.
Who should not use Meriofert Kit?+
Meriofert Kit should be avoided in individuals with known hypersensitivity to any component of the product, active ovarian cysts, uncontrolled thyroid disease, or those who are currently pregnant or breastfeeding unless directed by a specialist.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Follicle-Stimulating Hormone, Luteinising Hormone
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Ibsa Slovakia S.R.O.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU